latest news in companies
Moderna Agrees to $950 Million Settlement to End Global Patent Litigation
Cambridge, Tuesday, 3 March 2026.
In a significant move to clear its legal horizon, Moderna has agreed to pay $950 million to Arbutus Biopharma and Genevant Sciences, resolving worldwide disputes over the lipid nanoparticle technology used in its COVID-19 vaccines. While the deal eliminates future royalties, the total payout could swell by an additional $1.3 billion depending on the outcome of a federal appeal regarding government-contractor liability, potentially marking one of the largest patent settlements in pharmaceutical history.
Wildlight Entertainment to Permanently Shut Down Highguard Servers on March 12
Los Angeles, Tuesday, 3 March 2026.
Wildlight Entertainment confirms Highguard’s permanent shutdown on March 12, 2026. Despite Tencent backing and Apex Legends pedigree, the shooter collapsed in just 45 days, leaving the studio with under 20 employees.
Nano One Secures $3 Million Federal Funding to Strengthen North American Battery Supply Chain
Burnaby, Tuesday, 3 March 2026.
Natural Resources Canada has awarded Nano One Materials $3 million to advance its LFP cathode technology. With 98% of global supply currently originating in China, this investment aims to establish a resilient North American supply chain, supported by technical validation from strategic partner Sumitomo Metal Mining.
New Strategic Advisory Service Targets Southern Nevada’s Evolving Real Estate Landscape
Las Vegas, Tuesday, 3 March 2026.
Global Real Estate Advisor Yelena Horton introduces a specialized service for Southern Nevada, offering investors rare early access to high-value hospitality and mixed-use developments before they reach the broader market.
Mainz Biomed Director Signals Confidence with Strategic $6 Million Capital Injection
Mainz, Tuesday, 3 March 2026.
Director David Lazar has executed a high-stakes $6 million investment strategy in Mainz Biomed, utilizing preferred shares with aggressive conversion ratios to fund a pivot toward U.S. pancreatic cancer screening. This capital injection, confirmed in March 3 filings, is explicitly tied to future board control and stockholder approvals, marking a critical turning point for the diagnostics firm.
Fig Security Launches with $38 Million to Eliminate Silent Defense Failures
Mountain View, Tuesday, 3 March 2026.
Founded by former Google executives, Fig Security raised $38 million to identify invisible breakdowns in security operations, ensuring defenses remain resilient amidst constant technical changes.
Modular Medical Prices $12 Million Offering Above Market Value to Fuel Growth
San Diego, Tuesday, 3 March 2026.
Raising $12 million for insulin technology commercialization, the company successfully priced shares at a premium, signaling robust institutional confidence in its growth trajectory despite broader market challenges.